老年人糖尿病与肌少症关系的研究
Study on the Relationship between Diabetes Mellitus and Sarcopenia in the Elderly
DOI: 10.12677/ACM.2023.133670, PDF,   
作者: 张 芳, 樊 勇:新疆医科大学第一附属医院内分泌科,新疆 乌鲁木齐
关键词: 2型糖尿病肌少症Type 2 Diabetes Mellitus Sarcopenia
摘要: 糖尿病是以高血糖为特征的全身代谢性疾病,糖尿病患病人数逐年增多,各种并发症严重影响患者生活质量。肌少症是一种年龄相关性疾病,随病程进展严重威胁老年人身体。研究发现老年人中,糖尿病人群肌少症患病率是正常人群的三倍,与糖尿病相关的肌少症的发生原因可能与胰岛素抵抗、胰岛素分泌不足、代谢紊乱、慢性炎症及糖尿病其他并发症相关,但目前对于肌少症的治疗尚在探索阶段。本文根据国内外文献,对糖尿病合并肌少症的发病机制及相关治疗方法进行综述。
Abstract: Diabetes is a systemic metabolic disease characterized by hyperglycemia. The number of diabetes patients is increasing year by year, and the quality of life of patients is severely affected by various complications. Sarcopenia is an age-related disease, which is a serious threat to the elderly as the disease progresses. Studies have found that the prevalence of sarcopenia in the elderly population with diabetes is three times that of the normal population. The causes of diabetic sarcopenia may be related to insulin resistance, insufficient insulin secretion, metabolic disorders, chronic inflamma-tion and other complications of diabetes. However, the treatment of sarcopenia is still in the explo-ration stage. Based on the literature at home and abroad, this paper reviews the pathogenesis and treatment of diabetes mellitus with sarcopenia.
文章引用:张芳, 樊勇. 老年人糖尿病与肌少症关系的研究[J]. 临床医学进展, 2023, 13(3): 4673-4677. https://doi.org/10.12677/ACM.2023.133670

参考文献

[1] Dent, E., Morley, J.E., Cruz-Jentof, A.J., et al. (2019) International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and Management. Journal of Nutrition, Health and Aging, 22, 1148-1161. [Google Scholar] [CrossRef] [PubMed]
[2] 汪会琴, 胡如英, 武海滨, 俞敏. 2型糖尿病报告发病率研究进展[J]. 浙江预防医学, 2016, 28(1): 37-39+57. [Google Scholar] [CrossRef
[3] 柯志飞, 尚画雨, 雷槟恺, 曹春霞, 王祯, 王瑞元, 李俊平. 运动经外泌体防治肌少症的研究进展[J]. 生物化学与生物物理进展, 2022, 49(3): 492-502.
[4] Chung, J.H., Hwang, H.J., Han, C.H., et al. (2014) Association between Sarcopenia and Metabolic Syn-drome in Chronic Obstructive Pulmonary Disease: The Korea National Health and Nutrition Examination Survey (KNHANES) from 2008 to 2011. COPD, 12, 82-89. [Google Scholar] [CrossRef] [PubMed]
[5] Lu, C.W., Yang, K.C., Chang, H.H., et al. (2013) Sarcopenic Obesity Is Closely Associated with Metabolic Syndrome. Obe-sity Research & Clinical Practice, 7, e301-e307. [Google Scholar] [CrossRef] [PubMed]
[6] Maeda, K. and Akagi, J. (2014) Decreased Tongue Pressure Is Associated with Sarcopenia and Sarcopenic Dysphagia in the Elderly. Dysphagia, 30, 80-87. [Google Scholar] [CrossRef] [PubMed]
[7] Tarantino, U., Piccirilli, E., Fantini, M., et al. (2015) Sarcopenia and Fragility Fractures: Molecular and Clinical Evidence of the Bone-Muscle Interaction. The Journal of Bone and Joint Surgery. American Volume, 97, 429-437. [Google Scholar] [CrossRef
[8] Maeda, K. and Akagi, J. (2015) Sarcopenia Is an Independent Risk Factor of Dysphagia in Hospitalized Older People. Geriatrics & Gerontology International, 16, 515-521. [Google Scholar] [CrossRef] [PubMed]
[9] Pereira, S., Marliss, E.B., Morais, J.A., et al. (2008) Insulin Resistance of Protein Metabolism in Type 2 Diabetes. Diabetes, 57, 56-63. [Google Scholar] [CrossRef] [PubMed]
[10] Tanaka, K., Kanazawa, I. and Sugimoto, T. (2015) Reduction in Endogenous Insulin Secretion Is a Risk Factor of Sarcopenia in Men with Type 2 Diabetes Mellitus. Calcified Tissue International, 97, 385-390. [Google Scholar] [CrossRef] [PubMed]
[11] Hong, S., Chang, Y., Jung, H.S., et al. (2017) Relative Muscle Mass and the Risk of Incident Type 2 Diabetes: A Cohort Study. PLOS ONE, 12, e0188650. [Google Scholar] [CrossRef] [PubMed]
[12] Zhang, L., Li, M., Yi, W., et al. (2010) Effect on the Akt2 in Skeletal Muscle of Rats with Insulin Resistance Treated by Acupuncture. Journal of Acupuncture and Tuina Science, 8, 277-281. [Google Scholar] [CrossRef
[13] Timmerman, K.L., Lee, J.L., Dreyer, H.C., et al. (2010) Insulin Stimulates Human Skeletal Muscle Protein Synthesis via an Indirect Mechanism Involving Endothelial-Dependent Vasodilation and Mammalian Target of Rapamycin Complex 1 Signaling. The Journal of Clinical Endocrinology & Me-tabolism, 95, 3848-3857. [Google Scholar] [CrossRef] [PubMed]
[14] 王琴, 林萍, 任谦, 冯莉, 谢晓枫, 张彬, 高康璐. 肌肉减少症患者血清AMPK-ámRNA、SIRT1、GDF-8的水平及其临床意义[J]. 中华全科医学, 2022, 20(7): 1151-1154+1229. [Google Scholar] [CrossRef
[15] Thiebaud, D., Jacot, E., DeFronzo, R.A., et al. (1982) The Effect of Graded Doses of Insulin on Total Glucose Uptake, Glucose Oxidation, and Glucose Storage in Man. Dia-betes, 31, 957-963. [Google Scholar] [CrossRef] [PubMed]
[16] Scott, D., de Courten, B. and Ebeling, P.R. (2016) Sarcopenia: A Potential Cause and Consequence of Type 2 Diabetes in Australia’s Ageing Population. The Med-ical Journal of Australia, 205, 329-333. [Google Scholar] [CrossRef] [PubMed]
[17] Yu, Y., Du, H., Wei, S., et al. (2021) Adipocyte-Derived Exosomal MiR-27a Induces Insulin Resistancein Skeletal Muscle through Repression of PPARγ. Theranostics, 8, 2171-2188. [Google Scholar] [CrossRef] [PubMed]
[18] Garbossa, S.G. and Folli, F. (2020) Vitamin D, Sub-Inflammation and In-sulin Resistance. A Window on a Potential Role for the Interaction between Bone and Glucose Metabolism. Reviews in Endocrine and Metabolic Disorders, 18, 243-258. [Google Scholar] [CrossRef] [PubMed]